News

Zealand Pharma's Upcoming Investor Conference Schedule

Zealand Pharma's Upcoming Investor Conference Schedule

Zealand Pharma's Upcoming Investor Conference Schedule

Zealand Pharma A/S (Nasdaq: ZEAL), a pioneering biotechnology company, is gearing up for an exciting series of investor conferences this September. With its commitment to the research and development of innovative peptide-based medicines, Zealand Pharma aims to engage with investors and showcase its latest advancements in the biotechnology sector.

Key Conferences in September

In September 2025, Zealand Pharma will participate in several high-profile investor conferences, designed to promote its innovative drug discovery initiatives. These conferences present an excellent opportunity for investors to gain insights directly from the company's leadership.

Jefferies Swiss Healthcare Summit 2025

This summit, taking place on September 3, will feature Adam Lange, Vice President of Investor Relations. He will conduct investor meetings throughout the day, providing attendees with an in-depth understanding of the company’s strategic direction and growth potential.

Cantor Global Healthcare Conference 2025

Also scheduled for September 3-5 in New York, this conference will include Adam Steensberg, the President and Chief Executive Officer of Zealand Pharma. On September 4, he is set to host meetings with investors, as well as partake in a fireside chat at 8:00am EDT (14:00 CET). The chat promises to be an engaging discussion about the current landscape of the biotechnology industry and Zealand Pharma's role within it.

Wells Fargo and Morgan Stanley Conferences

Following these events, Zealand Pharma will also participate in the 2025 Wells Fargo Healthcare Conference from September 3 to 5 in Boston. During this important gathering, Adam Steensberg will engage with investors on September 5 and contribute to a fireside chat at 8:45am EDT (14:45 CET).

Morgan Stanley Annual Healthcare Conference

Adam Lange will lead investor engagements at the Morgan Stanley Annual Healthcare Conference on September 10 in New York. This event will allow for valuable interactions between the company's leadership and potential investors.

Final Conferences and Presentations

Later in the month, Zealand Pharma will partake in the Bank of America Global Healthcare Conference from September 23 to 25 in London. David Kendall, Executive Vice President and Chief Medical Officer, will run meetings on September 24 and 25 and is scheduled to give a presentation on September 25 at 10:45 am UKT (11:45 CET). Additionally, an audio webcast link will be available for viewing later on the company’s website, allowing for broader access to interested parties.

KBC Securities Life Sciences Conference

The final conference in September will be the KBC Securities Life Sciences Conference in Brussels on September 25. Adam Lange will again represent the company, hosting meetings with investors to deepen connections and share updates on Zealand Pharma’s innovative portfolio.

About Zealand Pharma

Established in 1998 and headquartered in Copenhagen, Zealand Pharma A/S (Nasdaq: ZEAL) concentrates on the development of peptide-based drugs. Over the years, the company has successfully brought several drug candidates into clinical progress, with two gaining market approval and three in late-stage development phases. Its partnerships with various pharmaceutical companies enhance its market reach and operational capacity.

For additional details about Zealand Pharma, including updates on its initiatives and conferences, please visit www.zealandpharma.com.

Frequently Asked Questions

What is the focus of Zealand Pharma?

Zealand Pharma is dedicated to the discovery and development of innovative peptide-based medicines aimed at addressing unmet medical needs.

When will Zealand Pharma participate in its next investor conference?

Zealand Pharma will participate in several conferences throughout September, starting with the Jefferies Swiss Healthcare Summit on September 3.

Who will represent Zealand Pharma at these conferences?

Key representatives include Adam Lange, Vice President of Investor Relations, and Adam Steensberg, President and Chief Executive Officer.

Are there any webcasts available for the fireside chats?

Yes, there will be live audio webcasts for some sessions, with recordings available after the events for those unable to attend.

How many drug candidates has Zealand Pharma developed?

Zealand Pharma has pushed over ten drug candidates into clinical development, with several achieving market readiness.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Monteverde Probes Four Key M&A Deals for Fairness

Updated Category News Views 4

Examining the Intricacies of Pending M&A The merger and acquisition landscape can be vicious, especially when the sharks—those pesky class action lawyers—start circling. And let me tell you, Monteverde & Associates PC is diving headfirst into the fray, launching inquiries into a handful of these deals. This isn't your first stroll down Wall Street if you’ve seen one...

Continue Reading
Lawsuit Highlights Inaction in School Bus Tragedy

Updated Category News Views 3

Seeking Justice Amid Heartbreak Tragedy rarely arrives whispered on the wind—more often, it's the train wreck some saw coming long before it hits. The tragic death of Jenna Menias, a 6-year-old from Frankfort, Illinois, falls squarely in this camp. The family's legal lions, Corboy & Demetrio, have slapped two school districts—District 210 and 157-C—with a wrongful...

Continue Reading
ARTBOX Brings Korean Lifestyle Magic to LA Pop-Up

Updated Category News Views 3

ARTBOX: From Seoul to La-La Land Here's what caught my eye. It's 2026, and Korean lifestyle retailer ARTBOX is making a splash in the U.S.—kicking things off with a pop-up in LA. Now, usually, I'd be skeptical about pop-ups, but you've got to admire the audacity and timing here. They've picked Melrose Avenue, a hotspot for all things trendy, to introduce their mix of...

Continue Reading
Black Culture Icon: Plastic-Covered Couch Takes Stage

Updated Category News Views 3

A Plastic-Laden Piece of History Makes Art Who'd have thought a plastic-covered couch would turn into a cultural artifact? This iconic staple in Black households has done just that, debuting at Brooklyn's CultureCon in a fresh guise. It's more than just an upcycled furniture piece; it's a living archive that encapsulates Black culture, joy, and resilience. The Heart...

Continue Reading
Blokees Unveils 90+ New Wonders at Shanghai Fest

Updated Category News Views 3

A Grand Stage for New Arrivals Picture this: In the bustling and glittering chaos that was the Wonder Festival Shanghai 2026, held from October 3 to 4, Blokees laid down a major marker. More than 500 products, an artillery of imagination and craftsmanship, were on deck across their key lines—Blokees Model Kits and BLOKEES WHEELS. With 90 brand-new creations making their...

Continue Reading
Monster Energy Dominates Skateboard Podium at SLS Paris

Updated Category News Views 3

Monster Energy's Skateboard Triumph Hold the front page, because Monster Energy just pulled off a clean sweep in Paris. The company's team riders dominated the Men's Skateboard Street competition at the SLS Paris 2026, with the iconic Nyjah Huston snagging the top spot. It's a story filled with triumph, grit, and a dash of raw talent in a vibrant field of international...

Continue Reading
Power Knot MEA Wins THE BIZZ 2026 for Excellence

Updated Category News Views 3

Setting the Pace in Waste Management If there's one thing that sticks in my craw, it's how businesses handle food waste. Power Knot Middle East (PKME) seems to have cracked the code by not just leading the charge in organic waste management but also bagging THE BIZZ 2026 award. They’re not just playing industry games; PKME's pulling the strings with real leadership and...

Continue Reading
Class Action Alerts: M&A Under Scrutiny

Updated Category News Views 3

Unpacking Monteverde's M&A Investigations Hold your horses, folks! The M&A Class Action Firm is stirring the pot with its latest inquiries into some high-profile mergers. We're looking at Lisata Therapeutics, Flag Ship Acquisition Corporation, Baldwin Insurance Group, and ACV Auctions. So what's got Juan Monteverde's legal eagles swooping in on these deals? Well, are we...

Continue Reading
SiBionics and PharmaSens Unveil Diabetes Tech at EASD

Updated Category News Views 3

Shaking Up Diabetes Care: New Tech Unveiled Imagine a world where managing diabetes isn't a juggling act with multiple devices. That's precisely the future SiBionics and PharmaSens are pitching at the European Association for the Study of Diabetes (EASD) 2026 in Milan. Now, let me tell you, these guys aren't just playing around with ideas; they're aiming to radically...

Continue Reading
Monteverde's Equity Alert: Scrutinizing Recent M&A Deals

Updated Category News Views 4

Diving Into M&A Deals Under Monteverde's Lens Wall Street’s not just about suits and skyscrapers; it’s about the nitty-gritty of deals and whether those numbers add up in the investor's favor. So, when Monteverde & Associates PC throws its weight into scrutinizing mergers and acquisitions, you better believe it's worth a second look. See, they’re digging into four...

Continue Reading

Top 5 Most Recently Viewed Articles

BRT Apartments Expands Portfolio with New Acquisition of Oaks at Victory

Updated Category News Views 161

BRT Apartments Corp. Expands Its Real Estate Portfolio GREAT NECK, N.Y. — BRT APARTMENTS CORP. (NYSE:BRT), a prominent player in the real estate investment trust sector, is excited to announce its acquisition of a new asset in the multifamily housing market. The company has successfully acquired Oaks at Victory, a garden-style apartment complex featuring 150 apartments....

Continue Reading
Kosmos Energy Achieves First LNG Production Milestone Today

Updated Category News Views 128

Kosmos Energy Achieves First LNG Production at Major Project Kosmos Energy (NYSE/LSE: KOS) has announced a significant milestone in its operations, achieving the first liquified natural gas (LNG) production at the Greater Tortue Ahmeyim (GTA) project, which is located offshore. This achievement showcases Kosmos's dedication to contributing to the world's energy needs...

Continue Reading
Oncor's 2024 Financial Performance and Major Capital Plan Unveiled

Updated Category News Views 1034

Oncor Electric Delivery Company LLC Reports 2024 Financial Results Oncor Electric Delivery Company LLC reported a net income of $968 million for the year ending December 31, 2024, reflecting an increase from $864 million in 2023. The rise of $104 million can be attributed to greater overall revenues driven by increased interim rates, higher transmission billing units, and...

Continue Reading
Dorel Industries Moves Forward with New Financing and Growth Strategy

Updated Category News Views 325

Dorel Industries Secures New Financing for Strategic Growth MONTRÉAL — Dorel Industries Inc. (TSX: DII.B, DII.A) is on the verge of finalizing important agreements with significant lenders that will bolster its financial structure. This involves establishing new credit facilities aggregating up to $310 million alongside a private placement of preferred shares totaling...

Continue Reading
GrubMarket Unveils New Catchweight Management for WholesaleWare

Updated Category News Views 81

GrubMarket's Innovative Catchweight Management Features GrubMarket, a leader in AI-powered technology solutions for the food supply chain, has recently launched new Catchweight Management features within its WholesaleWare platform. This cutting-edge innovation promises to significantly enhance how food distributors and wholesalers handle variable-weight products, such as...

Continue Reading